Nikhil Prasad Fact checked by:Thailand Medical News Team Jun 02, 2026 1 hour, 1 minute ago
Medical News: Heartburn, acid reflux, and upper stomach discomfort affect millions of people worldwide, often disrupting sleep, work, and daily activities. While medications that reduce stomach acid remain the standard treatment, many patients continue to struggle with symptoms or seek alternatives due to concerns about long-term medication use. A new large-scale study from Italy has now revealed that a novel protective gastrointestinal formulation called Tamacid-Pro® may offer significant relief for people suffering from reflux-related symptoms and digestive discomfort.
New study finds Tamacid-Pro® significantly reduces heartburn, reflux, and upper stomach discomfort in over 1,000 patients
Researchers from the IRCCS Azienda Ospedaliero-Universitaria di Bologna, the University of Bologna, the Tuscany North West Local Health Authority, the University of Milan, Riuniti Hospital of Livorno, and the University of Molise conducted a major prospective observational study involving more than 1,000 patients with persistent reflux symptoms.
A Common Condition with Limited Solutions
Gastroesophageal reflux disease, commonly known as GERD, affects a substantial portion of the global population. Typical symptoms include heartburn, acid regurgitation, and a burning sensation behind the breastbone. Many sufferers also experience symptoms linked to functional dyspepsia, including upper abdominal pain, discomfort, bloating, and burning sensations in the stomach region.
Diagnosing these conditions can be difficult because symptoms often overlap. Even when endoscopic examinations show no visible damage to the esophagus or stomach, patients may continue to experience severe symptoms that significantly reduce quality of life.
Researchers have increasingly focused on therapies that protect the lining of the digestive tract rather than simply suppressing acid production.
Evaluating a New Multicomponent Approach
The study enrolled 1,035 adults who had suffered upper gastrointestinal symptoms for at least two months. All participants underwent upper gastrointestinal endoscopy and tested negative for Helicobacter pylori infection.
Importantly, none showed visible structural damage that could explain their symptoms.
Participants received Tamacid-Pro® three times daily after meals for three months.
The formulation contains sodium alginate, Tamarindus indica extracts, Gingigel Pro®, ginger-derived compounds, xanthan gum, naringin, and other plant-based ingredients. Together, these ingredients are designed to create a protective barrier over irritated digestive tissues, improve gastric emptying, reduce sensitivity, and help prevent reflux episodes.
Researchers evaluated symptoms using the validated Reflux Disease Questionnaire before treatment and again after three months.
Dramatic Improvements Across All Symptoms
The results were striking. Every major symptom measured in the study improved significantly after three months of treatment. Patients reported reductions in the frequency and severity of heartburn
, acid taste in the mouth, regurgitation, chest discomfort, upper stomach pain, and burning sensations.
The overall GERD symptom score fell dramatically, indicating broad symptom relief. Improvements were also observed in the dyspepsia category, which measures upper stomach burning and pain.
Researchers noted that the improvements were highly statistically significant across all measured symptom categories. The benefits were not limited to one symptom type but extended across the entire spectrum of reflux-related complaints.
This
Medical News report notes that one of the most important findings was the improvement in patients who experienced both reflux symptoms and dyspeptic symptoms simultaneously. Such patients are often difficult to treat because conventional therapies do not always address the complex mechanisms involved.
Women Appeared to Benefit More
Another interesting observation emerged from the analysis. Women consistently experienced greater symptom improvement than men across several symptom categories, including reflux, regurgitation, and dyspepsia. Researchers believe this may be related to known differences in digestive sensitivity and symptom perception between males and females.
In contrast, regular alcohol consumption appeared to reduce the degree of improvement, particularly for heartburn symptoms. This finding supports previous research suggesting that alcohol can worsen reflux by weakening the lower esophageal sphincter and impairing natural protective mechanisms in the digestive tract.
Why the Formula May Work
The researchers believe the formulation's success stems from multiple complementary mechanisms.
Sodium alginate can form a floating "raft" barrier that helps prevent stomach contents from refluxing into the esophagus. Ginger-derived compounds may enhance stomach emptying and reduce digestive discomfort. Additional plant extracts may provide anti-inflammatory and protective effects on digestive tissues. Together, these actions may strengthen mucosal defenses while reducing irritation and symptom generation.
Importantly, this study represents the first clinical evidence supporting the use of Tamacid-Pro® in a large real-world patient population.
Conclusions
The findings suggest that Tamacid-Pro® may represent a promising new option for individuals suffering from reflux symptoms, particularly those whose endoscopic examinations show no visible abnormalities yet continue to experience significant discomfort. The formulation demonstrated broad effectiveness across heartburn, regurgitation, acid reflux, and dyspeptic symptoms, indicating that a mucosal-protective strategy may offer benefits beyond traditional acid suppression alone.
Although the results are encouraging, the researchers caution that the study was observational and lacked a placebo-controlled comparison group. Larger randomized clinical trials will be necessary to confirm these findings, determine long-term effectiveness, and better understand which patient groups are most likely to benefit from this innovative treatment approach.
The study findings were published in the peer reviewed journal: Pharmaceuticals.
https://www.mdpi.com/1424-8247/19/6/866
https://www.levantefarma.it/prodotti/integratori/tamacid-pro/
For the latest on Gastric Reflux, keep on logging to Thailand
Medical News.
Read Also:
https://www.thailandmedical.news/news/common-acid-reflux-drugs-may-trigger-dangerous-gut-infection
https://www.thailandmedical.news/news/proton-pump-inhibitors-ppis-impact-gut-health-by-translocating-oral-microbiota
https://www.thailandmedical.news/news/usage-of-proton-pump-inhibitors-associated-with-higher-risk-of-susceptibility-to-influenza-pneumonia-and-covid-19
https://www.thailandmedical.news/news/health-news-university-of-minnesota-study-finds-that-long-term-use-of-ppis-for-gastric-reflux-linked-to-higher-risk-of-developing-dementia
https://www.thailandmedical.news/news/proton-pump-inhibitors-ppis-increases-risk-of-fatty-liver-disease-by-disrupting-gut-microbiome-balance-according-to-korean-study
https://www.thailandmedical.news/news/ppis-or-acid-reflux-drugs-affects-cognitive-abilities-of-breast-cancer-survivors
https://www.thailandmedical.news/news/study-finds-another-negative-side-effect-of-ppi-usage,-this-time-linked-to-increased-risk-of-acute-gastroenteritis
https://www.thailandmedical.news/news/more-bad-news-for-users-of-proton-pump-inhibitors-(ppis),-as-these-gastric-reflux-drugs-are-implicated-in-cholangitis
https://www.thailandmedical.news/news/more-studies-emerging-that-ppis-(proton-pump-inhibitors)-linked-to-increased-risks-of-deaths
https://www.thailandmedical.news/news/new-study-links-ppis-to-kidney-disease-and-failure
https://www.thailandmedical.news/news/acid-reflux-medications-and-proton-pump-inhibitors-(ppis)-linked-to--kidney-disease
Share
Tweet
Share
